Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

cnbc.com/2025/07/09/hims-hers-generic-semaglutide-novo-nordisk-ozempic-wegovy-canada.html

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.

This story appeared on cnbc.com, 2025-07-09 13:01:47.
The Entire Business World on a Single Page. Free to Use →